Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL4359614

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of BSP-BODIPY binding to Nanoluc-tagged CECR2 (unknown origin) expressed in HEK293 cells measured after 4 to 6 hrs by NanoBRET assay
3
Total Activities
3
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Cell Type HEK293
Confidence 9 — Direct single protein target
Curated By Autocuration

Target

Chromatin remodeling regulator CECR2 (CHEMBL3108639)
Type SINGLE PROTEIN
Organism Homo sapiens

Publication

Optimization of Potent ATAD2 and CECR2 Bromodomain Inhibitors with an Atypical Binding Mode.
Lucas SCC, Atkinson SJ, Bamborough P, Barnett H, Chung CW, Gordon L, Mitchell DJ, Phillipou A, Prinjha RK, Sheppard RJ, Tomkinson NCO, Watson RJ, Demont EH.
J Med Chem (2020) 63 : 5212 -5241
PubMed 32321240 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 3 7.10 7.40

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL4465880 1 7.40
CHEMBL4577486 1 7.30
CHEMBL4449894 1 6.60

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL4465880 IC50 = 39.81 nM 7.40
CHEMBL4577486 IC50 = 50.12 nM 7.30
CHEMBL4449894 IC50 = 251.19 nM 6.60